FFCP PHASE1:Mm9::chr16:33985120..33985122,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=161|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr16:33985120..33985122,+|id=chr16:33985120..33985122,+|ontology_enrichment_celltype=CL:0000349!1.10e-52!3;CL:0000351!1.10e-52!3|ontology_enrichment_celltype_v019_2=CL:0000349,8.02e-16,3;CL:0000351,8.02e-16,3|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000358!1.10e-52!3;UBERON:0000307!1.10e-52!3;UBERON:0001987!2.13e-35!2;UBERON:0003124!2.13e-35!2;UBERON:0004340!2.13e-35!2;UBERON:0005631!5.11e-24!3;UBERON:0000478!5.11e-24!3;UBERON:0000158!5.11e-24!3;UBERON:0005795!2.61e-18!4;UBERON:0000995!2.61e-18!4;UBERON:0003975!7.12e-15!5;UBERON:0003134!1.08e-09!8;UBERON:0004175!1.00e-08!9;UBERON:0000474!1.00e-08!9;UBERON:0003100!2.59e-07!11|ontology_enrichment_uberon_v019_2=UBERON:0001987,9.50e-23,2;UBERON:0003124,9.50e-23,2;UBERON:0004340,9.50e-23,2;UBERON:0000358,8.02e-16,3;UBERON:0000307,8.02e-16,3;UBERON:0007010,8.02e-16,3;UBERON:0005631,1.12e-15,3;UBERON:0000478,1.12e-15,3;UBERON:0000158,1.12e-15,3;UBERON:0005795,4.02e-12,4;UBERON:0000995,4.02e-12,4;UBERON:0003975,5.59e-10,5;UBERON:0003134,9.78e-07,8|phase1_expression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|short_description=p@chr16:33985120..33985122,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=161 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr16:33985120..33985122,+ | |||
|description=CAGE_peak_at_chr16:33985120..33985122,+ | |||
|id=chr16:33985120..33985122,+ | |||
|ontology_enrichment_celltype=CL:0000349!1.10e-52!3;CL:0000351!1.10e-52!3 | |||
|ontology_enrichment_celltype_v019_2=CL:0000349,8.02e-16,3;CL:0000351,8.02e-16,3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000358!1.10e-52!3;UBERON:0000307!1.10e-52!3;UBERON:0001987!2.13e-35!2;UBERON:0003124!2.13e-35!2;UBERON:0004340!2.13e-35!2;UBERON:0005631!5.11e-24!3;UBERON:0000478!5.11e-24!3;UBERON:0000158!5.11e-24!3;UBERON:0005795!2.61e-18!4;UBERON:0000995!2.61e-18!4;UBERON:0003975!7.12e-15!5;UBERON:0003134!1.08e-09!8;UBERON:0004175!1.00e-08!9;UBERON:0000474!1.00e-08!9;UBERON:0003100!2.59e-07!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001987,9.50e-23,2;UBERON:0003124,9.50e-23,2;UBERON:0004340,9.50e-23,2;UBERON:0000358,8.02e-16,3;UBERON:0000307,8.02e-16,3;UBERON:0007010,8.02e-16,3;UBERON:0005631,1.12e-15,3;UBERON:0000478,1.12e-15,3;UBERON:0000158,1.12e-15,3;UBERON:0005795,4.02e-12,4;UBERON:0000995,4.02e-12,4;UBERON:0003975,5.59e-10,5;UBERON:0003134,9.78e-07,8 | |||
|phase1_expression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| |||
|short_description=p@chr16:33985120..33985122,+ | |||
}} |
Latest revision as of 08:32, 6 August 2015
Short description: | p@chr16:33985120..33985122, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr16:33985120..33985122, + |
Coexpression cluster: | MCL_coexpression_mm9:161 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
extraembryonic cell | 8.02e-16 | 3 |
trophoblast cell | 8.02e-16 | 3 |
Ontology term | p-value | n |
---|---|---|
placenta | 9.50e-23 | 2 |
chorion | 9.50e-23 | 2 |
allantois | 9.50e-23 | 2 |
blastocyst | 8.02e-16 | 3 |
blastula | 8.02e-16 | 3 |
cleaving embryo | 8.02e-16 | 3 |
extraembryonic membrane | 1.12e-15 | 3 |
extraembryonic structure | 1.12e-15 | 3 |
membranous layer | 1.12e-15 | 3 |
embryonic uterus | 4.02e-12 | 4 |
uterus | 4.02e-12 | 4 |
internal female genitalia | 5.59e-10 | 5 |
female reproductive organ | 9.78e-07 | 8 |